TE_13399
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | LNC-LBCS |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 259.23 |
| Counts of samples | TCGA_tumor:229; TCGA_normal:0; GTEx:0 |
| TSS | chr6(-):19765273 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_13399.31 | LNC-LBCS | Chimeric | Non-coding | Non-coding | chr6(-):19730759,19730779,19734451,19734595,19749648,19749758,19750288,19750560,19765147,19765274 |
| teRNA_13399.32 | LNC-LBCS | Chimeric | Non-coding | Non-coding | chr6(-):19730702,19730722,19733405,19733474,19734451,19734595,19744031,19744134,19749648,19749758,19750288,19750560,19765147,19765274 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
